Most skin cancers are preventable, and if caught early enough, generally treatable. And yet, despite rapidly increasing rates and fervent warnings, not everyone is willing to apply sunscreen or stay in the shade. It is our responsibility to continue advancing our screening and monitoring options that catch skin cancer while it is still curable.
Breakthroughs in biomarker and polymerase chain reaction (PCR) research mean we now have diagnostic tools that enable oncology labs to test with confidence.
